首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Reduced cell attachment to poly(2‐hydroxyethyl methacrylate)‐coated ventricular catheters in vitro in vitro
【24h】

Reduced cell attachment to poly(2‐hydroxyethyl methacrylate)‐coated ventricular catheters in vitro in vitro

机译:在体外减少到聚(2-羟乙基甲基丙烯酸酯)涂覆的室性导管的细胞附着

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract The majority of patients with hydrocephalus are dependent on ventriculoperitoneal shunts for diversion of excess cerebrospinal fluid. Unfortunately, these shunts are failure‐prone and over half of all life‐threatening pediatric failures are caused by obstruction of the ventricular catheter by the brain's resident immune cells, reactive microglia and astrocytes. Poly(2‐hydroxyethyl methacrylate) (PHEMA) hydrogels are widely used for biomedical implants. The extreme hydrophilicity of PHEMA confers resistance to protein fouling, making it a strong candidate coating for ventricular catheters. With the advent of initiated chemical vapor deposition (iCVD), a solvent‐free coating technology that creates a polymer in thin film form on a substrate surface by introducing gaseous reactant species into a vacuum reactor, it is now possible to apply uniform polymer coatings on complex three‐dimensional substrate surfaces. iCVD was utilized to coat commercially available ventricular catheters with PHEMA. The chemical structure was confirmed on catheter surfaces using Fourier transform infrared spectroscopy and X‐ray photoelectron spectroscopy. PHEMA coating morphology was characterized by scanning electron microscopy. Testing PHEMA‐coated catheters against uncoated clinical‐grade catheters in an in vitro hydrocephalus catheter bioreactor containing co‐cultured astrocytes and microglia revealed significant reductions in cell attachment to PHEMA‐coated catheters at both 17‐day and 6‐week time points. ? 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1268–1279, 2018.
机译:摘要大多数脑积水患者依赖于脑室分流,用于转移过量的脑脊液。不幸的是,这些分流器是易于失败的,并且所有危及危及生命的儿科失败的一半是由大脑常驻免疫细胞,反应性小胶质细胞和星形胶质细胞阻塞心室导管引起的。聚(2-羟乙基甲基丙烯酸甲酯)(PHEMA)水凝胶广泛用于生物医学植入物。 PHEMA的极端亲水性赋予抗蛋白质污垢的抗性,使其成为心室导管的强烈候选涂层。随着引发的化学气相沉积(ICVD)的出现,通过将气态反应物物质引入真空反应器中,在基板表面上以薄膜形成聚合物的无溶剂涂布技术,现在可以将均匀的聚合物涂层施加均匀的聚合物涂层复杂的三维衬底表面。 ICVD用于涂上与PHEMA的市售心室导管。使用傅里叶变换红外光谱和X射线光电子谱管在导管表面上确认化学结构。通过扫描电子显微镜表征PhEMA涂层形态。在含有共培养的星形胶质细胞和微胶质细胞和微胶质细胞的体外脑膜导管生物反应器中测试Phema涂覆的导管,含有微胶质细胞和微胶质细胞的显着减少在17天和6周的时间点。还2017年Wiley期刊,Inc。J生物保解率B部分:苹果生物检索物,106B:1268-1279,2018。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号